Review: molecular genetics and pathology of hereditary small vessel diseases of the brain.
Advances in molecular genetics have enabled identification of several monogenic conditions involving small vessels predisposing to ischaemic and haemorrhagic strokes and diffuse white matter disease. With emphasis on cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), we review the molecular pathogenesis of recently characterized disorders including cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), retinal vasculopathy with cerebral leukodystrophy (RVCL) and the Collagen type IV, alpha 1 (COL4A1)-related disorders. CADASIL remains the most common hereditary small vessel disease (SVD) caused by >190 different mutations in the NOTCH3 gene, which encodes a cell-signalling receptor. Mutant NOTCH3 instigates degeneration of vascular smooth muscle cells in small arteries and arterioles leading to recurrent lacunar infarcts. Mutations in the serine protease HTRA1 gene are associated with CARASIL. Aberrant HTRA1 activity results in increased transforming growth factor-β signalling provoking multiple actions including vascular fibrosis and extracellular matrix synthesis. The RVCL disorders characterized by profound retinopathy are associated with mutations in TREX1, which encodes an abundant 3'-5' DNA-specific exonuclease. TREX1 mutations lead to detrimental gain-of-function or insufficient quantities of enzyme. The COL4A1-related disorders are highly variable comprising four major phenotypes with overlapping systemic and central nervous system features including SVD with cerebral haemorrhages in children and adults. Mutant COL4A1 likely disrupts the extracellular matrix resulting in fragile vessel walls. The hereditary SVDs albeit with variable phenotypes demonstrate how effects of different defective genes converge to produce the characteristic arteriopathy and microvascular disintegration leading to vascular cognitive impairment.
Institute for Ageing and Health, Wolfson Research Centre, Newcastle University, Campus for Ageing & Vitality, Newcastle upon Tyne, UK.
Y
Y
Yamamoto
L
L
Craggs
M
M
Baumann
H
H
Kalimo
R N
RN
Kalaria
D000818:Animals; D001921:Brain / Q000473:pathology*; D046589:CADASIL / Q000235:genetics / Q000473:pathology; D002196:Capillaries / Q000473:pathology*; D002539:Cerebral Arterial Diseases / Q000235:genetics / Q000473:pathology; D002544:Cerebral Infarction / Q000235:genetics / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000235:genetics* / Q000473:pathology*; D024141:Collagen Type IV / Q000235:genetics; D006801:Humans; D056784:Leukoencephalopathies / Q000235:genetics / Q000473:pathology; D008967:Molecular Biology; D009154:Mutation / Q000235:genetics / Q000502:physiology; D000071656:Receptor, Notch3; D051880:Receptors, Notch / Q000235:genetics / Q000502:physiology; D012171:Retinal Vessels / Q000473:pathology; D015398:Signal Transduction / Q000235:genetics
C547475:COL4A1 protein, human; D024141:Collagen Type IV; C499374:NOTCH3 protein, human; D000071656:Receptor, Notch3; D051880:Receptors, Notch